Emergen Research's latest market research report, titled Global Targeted Sequencing Market, provides estimated market size and shares, latest industry trends, global market growth rates, key drivers and opportunities, constraints, product segmentation, and major market players. Cost structure, market size, competitive landscape, product portfolio and specifications, and company profiles.

This report is a fair prototype of the Targeted Sequencing-industry containing an in-depth study of the global Targeted Sequencing market. This report serves as a valuable source of data and information related to this industry. It covers various industry aspects with a particular focus on market scope and application areas. The report identifies the fundamental business strategies adopted by industry experts and offers an insightful study on the value chains and distribution channels of the global market. The report authors have also analyzed current industry trends, growth potential, current overview, and market limitations.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4463

The Targeted Sequencing Market is expected to grow from an estimated USD 3.61 Billion in 2025 to USD 11.03 Billion in 2035, at a CAGR of 13.2%.

One of the main factors contributing to the growth of the targeted sequencing market is the increasing demand for precision medicine. Precision medicine, also referred to as personalized healthcare, is a novel approach wherein medical treatment is tailored according to an individual's unique characteristics, such as genetics, lifestyle, and environmental factors.

The trend is now shifting to personalized medicine, and the approach is going to completely revolutionize the diagnosis and treatment of diseases. A deeper understanding of how genetic variation influences disease susceptibility and treatment response helps clinicians tailor therapy for the individual, increasing the efficacy of treatments and minimizing side effects.

Targeted sequencing has become an important approach in precision medicine, which enables the identification of a certain genetic variation that may lead to diseases. Targeted sequencing will enable clinicians to pinpoint mutations or abnormalities in the genome, thus diagnosing the condition more precisely, and further understand the mechanism behind the disease.

This targeted approach will also help in choosing the most effective treatments based on a patient's unique genetic profile. For instance, it can be used in cancer treatment to identify genetic mutations that make tumour cells resistant to drugs, hence helping in the choice of more effective targeted therapies.

In November 2022, BGI Genomics and the University of Pécs entered a partnership with the opening of a joint laboratory in Hungary. This collaboration is being eyed for the advancement of genomic sequencing and clinical diagnosis services, supporting innovation in developing precision medicine solutions in Central and Eastern Europe.

The official opening of the lab will further accelerate these actions, in which both BGI Genomics and UP stand to improve their contributions toward.

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Targeted Sequencing market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Targeted Sequencing market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Targeted Sequencing market.

Market Segmentation:

The report bifurcates the Targeted Sequencing market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.

Competition in the targeted sequencing market is quite intense. There are a number of participants in this industry, and the major ones among them include Agilent Technologies, Inc., Thermo Fisher Scientific Inc., and Illumina, Inc., among many more leading technologies in different ways by offering a range of targeted sequencing solutions.

Agilent Technologies provides state-of-the-art platforms for genomics research and is one of the key enablers of precision medicine. Thermo Fisher Scientific focuses on NGS platforms and reagents that enable high-throughput analysis.

Illumina has maintained its lead in the sequencing space by offering advanced sequencing systems, data analysis tools, and reagents. The Key players operating in the Targeted Sequencing Market includes Agilent Technologies, Inc., Azenta, Inc., BGI Group, CD Genomics, F. Hoffmann-La Roche Ltd, Daicel Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Illumina, Inc., LGC Limited, and Others.

For Instance, BGI Group engages in the provision of highly valued sequencing services and solutions, focusing on genomics research and precision medicine. Roche, the world's healthcare company, combines diagnostics with genomic sequencing to advance wide solutions that meet both clinical and research needs. Integration of such technologies facilitates personalized health care on diagnosis and treatment strategies related to various diseases.

Some of the key companies in the global Targeted Sequencing market include:

• Agilent Technologies, Inc.
• Azenta, Inc.
• BGI Group
• CD Genomics
• Hoffmann-La Roche Ltd
• Daicel Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Illumina, Inc.
• LGC Limited

Target Audience of the Global Targeted Sequencing Market Report:

• Key Market Players
• Investors
• Venture capitalists
• Small- and medium-sized and large enterprises
• Third-party knowledge providers
• Value-Added Resellers (VARs)
• Global market producers, distributors, traders, and suppliers
• Research organizations, consulting companies, and various alliances interested in this sector
• Government bodies, independent regulatory authorities, and policymakers

• Application Outlook (Revenue, USD Billion; 2020-2035)

  • Cancer
  • Reproductive Health
  • Hereditary Diseases
  • Neurological Disorders
  • Infectious Diseases
  • Cardiovascular Diseases
  • Rare Disease
  • Other Applications

• End-Use Outlook (Revenue, USD Billion; 2020-2035)

  • Diagnostic and Clinical Laboratories
  • Academic and Research Institutions
  • Pharmaceutical and Biotech Companies
  • Other End-Use

• Product Type Outlook (Revenue, USD Billion; 2020-2035)

  • Instruments
  • Services
  • Kits/Panels and Assays
  • Others

• Target Enrichment Method Outlook (Revenue, USD Billion; 2020-2035)

  • Hybridization Capture
  • Amplicon Sequencing
  • Other Target Enrichment Methods

• Regional Outlook (Revenue, USD Billion; 2020-2035)

  • North America
    1. United States
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. United Kingdom
    4. Italy
    5. Spain
    6. Benelux
    7. Rest of Europe
  • Asia-Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of Asia-Pacific
  • Latin America
    1. Brazil
    2. Rest of Latin America
  • Middle East and Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Turkey
    5. Rest of MEA

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/targeted-sequencing-market

Competitive Terrain:

The global Targeted Sequencing industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

Advancements in Sequencing Technologies

The growth in the market for targeted sequencing has been triggered by massive development in technologies of sequencing that had bridged gaps of accuracy, affordability, and accessibility for the target population.

It is due to this tremendous improvement in technology that brought about the emergence of what is currently called Next-Generation Sequencing. NGS is a high-throughput method that enables the simultaneous sequencing of millions of DNA fragments, thereby allowing extremely high resolution and depth of analysis either of selected genes or regions within the genome.

This technology has drastically reduced sequencing time and costs, which makes it increasingly applicable both in research and clinically. In March 2023, SOPHiA GENETICS announced a new partnership with Qiagen to integrate QIAseq reagent technology with the DDM platform. This collaboration will further tumor analysis by empowering next-generation sequencing.

Targeted sequencing has become increasingly accurate owing to the continuously improved sensitivities and precisions in NGS platforms. Thus, low-frequency variants and rare mutations can be identified with high confidence, especially in applications such as cancer genomics where only a small proportion of cells have mutations.

Furthermore, the capability for sequencing of several targets simultaneously, also referred to as multiplexing, enables researchers and clinicians to target their genes or regions of interest while minimizing errors and increasing reliability.

Key reasons to buy the Global Targeted Sequencing Market report:

1. The latest report comprehensively studies the global Targeted Sequencing market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
2. The report offers an insightful analysis of the regional outlook of the market.
3. It offers a detailed account of the end-use applications of the products & services offered by this industry.
4. The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4463

Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com